SE9003100D0 - Lipid formulation system - Google Patents
Lipid formulation systemInfo
- Publication number
- SE9003100D0 SE9003100D0 SE9003100A SE9003100A SE9003100D0 SE 9003100 D0 SE9003100 D0 SE 9003100D0 SE 9003100 A SE9003100 A SE 9003100A SE 9003100 A SE9003100 A SE 9003100A SE 9003100 D0 SE9003100 D0 SE 9003100D0
- Authority
- SE
- Sweden
- Prior art keywords
- lipid
- matrix
- particle forming
- lipid particle
- forming matrix
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Birds (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Saccharide Compounds (AREA)
- Fertilizers (AREA)
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9003100A SE9003100D0 (sv) | 1990-09-28 | 1990-09-28 | Lipid formulation system |
IE324691A IE62194B1 (en) | 1990-09-28 | 1991-09-13 | Lipid formulation systems |
DK91919389.6T DK0514506T3 (da) | 1990-09-28 | 1991-09-24 | Lipid-formuleringssystem |
DE69119400T DE69119400T2 (de) | 1990-09-28 | 1991-09-24 | System auf basis einer lipidformulierung |
PCT/SE1991/000639 WO1992005771A1 (en) | 1990-09-28 | 1991-09-24 | Lipid formulation system |
JP3516564A JP2855594B2 (ja) | 1990-09-28 | 1991-09-24 | 脂質粒子形成マトリックス及びその製造方法 |
CA002069760A CA2069760C (en) | 1990-09-28 | 1991-09-24 | Lipid formulation system |
AU87105/91A AU645143B2 (en) | 1990-09-28 | 1991-09-24 | Lipid formulation system |
ES91919389T ES2088024T3 (es) | 1990-09-28 | 1991-09-24 | Sistema de formulacion de lipidos. |
AT91919389T ATE137667T1 (de) | 1990-09-28 | 1991-09-24 | System auf basis einer lipidformulierung |
EP91919389A EP0514506B1 (en) | 1990-09-28 | 1991-09-24 | Lipid formulation system |
PT99113A PT99113B (pt) | 1990-09-28 | 1991-09-27 | Processo para a preparacao de matrizes que originam particulas de lipidos |
NO921231A NO304729B1 (no) | 1990-09-28 | 1992-05-26 | Lipidpartikkeldannende matriks |
FI922452A FI107696B (fi) | 1990-09-28 | 1992-05-27 | Lipidipartikkelinmuodostusmatriisi ja menetelmä sen valmistamiseksi |
US08/242,054 US5665379A (en) | 1990-09-28 | 1994-05-13 | Lipid particle forming matrix, preparation and use thereof |
GR960402032T GR3020674T3 (en) | 1990-09-28 | 1996-07-31 | Lipid formulation system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9003100A SE9003100D0 (sv) | 1990-09-28 | 1990-09-28 | Lipid formulation system |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9003100D0 true SE9003100D0 (sv) | 1990-09-28 |
Family
ID=20380490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9003100A SE9003100D0 (sv) | 1990-09-28 | 1990-09-28 | Lipid formulation system |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0514506B1 (xx) |
JP (1) | JP2855594B2 (xx) |
AT (1) | ATE137667T1 (xx) |
AU (1) | AU645143B2 (xx) |
CA (1) | CA2069760C (xx) |
DE (1) | DE69119400T2 (xx) |
DK (1) | DK0514506T3 (xx) |
ES (1) | ES2088024T3 (xx) |
FI (1) | FI107696B (xx) |
GR (1) | GR3020674T3 (xx) |
IE (1) | IE62194B1 (xx) |
NO (1) | NO304729B1 (xx) |
PT (1) | PT99113B (xx) |
SE (1) | SE9003100D0 (xx) |
WO (1) | WO1992005771A1 (xx) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5260065A (en) * | 1991-09-17 | 1993-11-09 | Micro Vesicular Systems, Inc. | Blended lipid vesicles |
SE9200951D0 (sv) * | 1992-03-27 | 1992-03-27 | Kabi Pharmacia Ab | Pharmaceutical composition containing a defined lipid system |
SE9200952D0 (sv) * | 1992-03-27 | 1992-03-27 | Kabi Pharmacia Ab | Pharmaceutical carrier system containing defined lipids |
DK0743851T3 (da) * | 1994-02-04 | 2001-09-03 | Lipocore Holding Ab | Lipofile bærepræparater |
DE4447287C1 (de) * | 1994-12-30 | 1996-11-07 | Cevc Gregor | Präparat zum Wirkstofftransport durch Barrieren |
SE9703691D0 (sv) | 1997-10-10 | 1997-10-10 | Astra Ab | Pharmaceutical compositions |
GB2344520A (en) * | 1998-12-08 | 2000-06-14 | Phares Pharm Res Nv | Pharmaceutical carriers comprising lipids and polymers |
DE69825495T2 (de) | 1998-12-23 | 2005-07-28 | Idea Ag | Verbesserte formulierung zur topischen, nichtinvasiven anwendung in vivo |
SE0000730D0 (sv) * | 2000-03-06 | 2000-03-06 | Scotia Holdings Plc | Lipid carrier |
SE0200475D0 (sv) * | 2002-02-15 | 2002-02-15 | Ltp Lipid Technologies Provide | Oral farmaceutisk beredning |
SE0201922D0 (sv) * | 2002-06-20 | 2002-06-20 | Ltp Lipid Technologies Provide | Koagulationshindrande komposition (Anticoagulant Composition) |
FR2868704B1 (fr) * | 2004-04-07 | 2007-09-14 | Ethypharm Sa | Utilisation de lipides pour ameliorer la biodisponibilite de principes actifs proteiques en formulations injectables sous cutanees ou intra-musculaires |
NZ550320A (en) | 2004-04-15 | 2010-02-26 | Chiasma Inc | Compositions capable of facilitating penetration across a biological barrier |
JP2008539230A (ja) * | 2005-04-28 | 2008-11-13 | ガレニカ テクノロジー アンチエボラグ | 脂質相を含む薬学的投与形態 |
ES2385513T3 (es) * | 2005-10-11 | 2012-07-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Composición para administración nasal |
BRPI0918652B1 (pt) | 2008-09-17 | 2021-10-19 | Chiasma, Inc. | Composição farmacêutica compreendendo um meio hidrofóbico e uma forma sólida que compreende polipeptídeo e sal de ácido graxo de cadeia média, processo de produção da mesma e forma de dosagem oral |
CN101926757B (zh) * | 2010-09-01 | 2013-01-02 | 北京大学 | 一种难溶性药物的液体组合物及其制备方法 |
MA41462A (fr) | 2015-02-03 | 2021-05-12 | Chiasma Inc | Méthode de traitement de maladies |
US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
CN117580560A (zh) * | 2021-05-03 | 2024-02-20 | Mcal治疗公司 | 微粉化脂质 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT8219012A0 (it) * | 1982-01-06 | 1982-01-06 | Ausonia Farma Srl | Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche. |
DE3585967D1 (de) * | 1984-03-08 | 1992-06-11 | Phares Pharma Holland | Liposombildende zusammensetzung. |
GB8613811D0 (en) * | 1986-06-06 | 1986-07-09 | Phares Pharm Res Nv | Composition & method |
US4610868A (en) * | 1984-03-20 | 1986-09-09 | The Liposome Company, Inc. | Lipid matrix carriers for use in drug delivery systems |
SE8603812D0 (sv) * | 1986-09-12 | 1986-09-12 | Draco Ab | Administration of liposomes to mammals |
ATE115403T1 (de) * | 1987-01-27 | 1994-12-15 | Vestar Inc | Aus phospholipiden bestehende darreichungsform für wasserunlösliche wirksubstanzen. |
-
1990
- 1990-09-28 SE SE9003100A patent/SE9003100D0/xx unknown
-
1991
- 1991-09-13 IE IE324691A patent/IE62194B1/en not_active IP Right Cessation
- 1991-09-24 DK DK91919389.6T patent/DK0514506T3/da active
- 1991-09-24 DE DE69119400T patent/DE69119400T2/de not_active Expired - Fee Related
- 1991-09-24 AU AU87105/91A patent/AU645143B2/en not_active Ceased
- 1991-09-24 WO PCT/SE1991/000639 patent/WO1992005771A1/en active IP Right Grant
- 1991-09-24 JP JP3516564A patent/JP2855594B2/ja not_active Expired - Fee Related
- 1991-09-24 AT AT91919389T patent/ATE137667T1/de not_active IP Right Cessation
- 1991-09-24 ES ES91919389T patent/ES2088024T3/es not_active Expired - Lifetime
- 1991-09-24 CA CA002069760A patent/CA2069760C/en not_active Expired - Fee Related
- 1991-09-24 EP EP91919389A patent/EP0514506B1/en not_active Expired - Lifetime
- 1991-09-27 PT PT99113A patent/PT99113B/pt not_active IP Right Cessation
-
1992
- 1992-05-26 NO NO921231A patent/NO304729B1/no unknown
- 1992-05-27 FI FI922452A patent/FI107696B/fi active
-
1996
- 1996-07-31 GR GR960402032T patent/GR3020674T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
IE913246A1 (en) | 1992-04-08 |
ES2088024T3 (es) | 1996-08-01 |
IE62194B1 (en) | 1994-12-28 |
FI922452A (fi) | 1992-05-27 |
DE69119400D1 (de) | 1996-06-13 |
FI922452A0 (fi) | 1992-05-27 |
NO922084L (no) | 1992-05-26 |
DK0514506T3 (da) | 1996-08-12 |
CA2069760A1 (en) | 1992-03-29 |
JP2855594B2 (ja) | 1999-02-10 |
JPH05503711A (ja) | 1993-06-17 |
ATE137667T1 (de) | 1996-05-15 |
EP0514506A1 (en) | 1992-11-25 |
CA2069760C (en) | 1998-02-10 |
WO1992005771A1 (en) | 1992-04-16 |
EP0514506B1 (en) | 1996-05-08 |
PT99113A (pt) | 1992-08-31 |
NO304729B1 (no) | 1999-02-08 |
AU8710591A (en) | 1992-04-28 |
PT99113B (pt) | 1999-02-26 |
FI107696B (fi) | 2001-09-28 |
DE69119400T2 (de) | 1996-12-05 |
GR3020674T3 (en) | 1996-10-31 |
NO922084D0 (no) | 1992-05-26 |
AU645143B2 (en) | 1994-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0514506T3 (da) | Lipid-formuleringssystem | |
DE3681755D1 (de) | Wirkstofftraeger und diesen enthaltende arzneimittel. | |
FR2778406B1 (fr) | Derives d'alpha-cetoamides, procede pour leur preparation, preparations pharmaceutiques les contenant, et leur utilisation en tant que medicaments anti-viraux | |
DE68920394D1 (de) | Heterozyklische Verbindungen und Arzneimittel, die die Wirkung von Antikrebsmitteln verstärken, welche diese als wirksame Bestandteile enthalten. | |
AR011080A1 (es) | Composicion en polvo seco, proceso para su preparacion y uso de dicha composicion para la fabricacion del medicamento | |
IE54084B1 (en) | Medicaments with a high degree of solubility and method for their production | |
FR2334359A1 (fr) | Derives de l'isoquinoleine, leur preparation et medicaments contenant ces substances | |
FR2679906B1 (fr) | Nouvelles (isoquinolein-5 yl) sulfonamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
ES2093440T3 (es) | Derivados en la serie de la vitamina d con modificaciones en la posicion 20, procedimiento para su preparacion, productos intermedios para este procedimiento, preparados farmaceuticos que contienen estos derivados asi como su utilizacion para la preparacion de medicamentos. | |
HUT70150A (en) | Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines, pharmaceutical compositions containing them and method for its preparation | |
KR900005990A (ko) | 차전자(psyllium)-함유 생성물 | |
ES2058988T3 (es) | Preparacion de medicamentos para el tratamiento sistemico de peces ornamentales y utiles. | |
Khan et al. | Development of microencapsulation: A review of literature | |
KR970032872A (ko) | 아세틸살리실산을 함유하는 피부 손상 처치용 약물 | |
NO933323D0 (no) | Naerings- og medikamentblandinger paa basis av kitosan for administrering til droevtyggere | |
IL82523A0 (en) | Microbicidal compositions,their manufacture and drugs containing them | |
JPS5225015A (en) | Process for preparing fine granular drugs | |
ATE28566T1 (de) | Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin. | |
FI960688A (fi) | Substituoituja bentseenisulfonyyliureoita ja -tioureoita, menetelmä niiden valmistamiseksi ja näihin yhdisteisiin perustuvien farmaseuttisten valmisteiden käyttö sekä niitä sisältäviä lääkkeitä | |
JPS61178914A (ja) | ヒト及び動物の耳への局所投与用不溶性薬剤 | |
FR2676648B1 (fr) | Nouvelles compositions, leur procede de preparation et leurs applications comme substance active de medicament antigrippal ou antiviral. | |
FR2732681B1 (fr) | Derives de 10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one, leur preparation et les medicaments les contenant | |
BE862053A (fr) | Peptides contenant de la phenylglycine utiles comme medicaments, procede pour leur preparation et compositions pharmaceutiques en contenant | |
BE874154A (fr) | Derives de l'eburnamonine, leur preparation et medicaments contenant ces substances | |
KR100486794B1 (ko) | 다른 상 운반체 사이에서 하나 또는 그 이상의 활성인자를 이동시키는 방법 |